1. Albers GW, Marks MP, Kemp S, Christensen S, Tsai JP, OrtegaGutierrez S, et al. Thrombectomy for stroke at 6 to 16 hours with selection by perfusion imaging.
N Engl J Med 2018;378:708-718.
2. Nogueira RG, Jadhav AP, Haussen DC, Bonafe A, Budzik RF, Bhuva P, et al. Thrombectomy 6 to 24 hours after stroke with a mismatch between deficit and infarct.
N Engl J Med 2018;378:11-21.
3. Mokin M, Ansari SA, McTaggart RA, Bulsara KR, Goyal M, Chen M, et al. Indications for thrombectomy in acute ischemic stroke from emergent large vessel occlusion (ELVO): report of the SNIS Standards and Guidelines Committee.
J Neurointerv Surg 2019;11:215-220.
4. Wheeler HM, Mlynash M, Inoue M, Tipirnini A, Liggins J, Bammer R, et al. The growth rate of early DWI lesions is highly variable and associated with penumbral salvage and clinical outcomes following endovascular reperfusion.
Int J Stroke 2015;10:723-729.
5. Hill MD, Goyal M. Treat fast but abandon time from ischemic stroke onset as a criterion for treatment: the DAWN and DEFUSE-3 trials.
Int J Stroke 2018;13:344-347.
6. Gadhia J, Starkman S, Ovbiagele B, Ali L, Liebeskind D, Saver JL. Assessment and improvement of figures to visually convey benefit and risk of stroke thrombolysis.
Stroke 2010;41:300-306.
7. Tokunboh I, Vales Montero M, Zopelaro Almeida MF, Sharma L, Starkman S, Szeder V, et al. Visual aids for patient, family, and physician decision making about endovascular thrombectomy for acute ischemic stroke.
Stroke 2018;49:90-97.
8. Samsa GP, Matchar DB, Goldstein L, Bonito A, Duncan PW, Lipscomb J, et al. Utilities for major stroke: results from a survey of preferences among persons at increased risk for stroke.
Am Heart J 1998;136(4 Pt 1):703-713.
9. Howard G, Waller JL, Voeks JH, Howard VJ, Jauch EC, Lees KR, et al. A simple, assumption-free, and clinically interpretable approach for analysis of modified Rankin outcomes.
Stroke 2012;43:664-669.
10. Saver JL, Gornbein J, Grotta J, Liebeskind D, Lutsep H, Schwamm L, et al. Number needed to treat to benefit and to harm for intravenous tissue plasminogen activator therapy in the 3- to 4.5-hour window: joint outcome table analysis of the ECASS 3 trial.
Stroke 2009;40:2433-2437.
11. Durand MA, Witt J, Joseph-Williams N, Newcombe RG, Politi MC, Sivell S, et al. Minimum standards for the certification of patient decision support interventions: feasibility and application.
Patient Educ Couns 2015;98:462-468.
12. Leslie-Mazwi TM, Hamilton S, Mlynash M, Patel AB, Schwamm LH, Lansberg MG, et al. DEFUSE 3 non-DAWN patients.
Stroke 2019;50:618-625.
13. Bivard A, Huang X, Levi CR, Campbell BC, Cheripelli BK, Chen C, et al. Comparing mismatch strategies for patients being considered for ischemic stroke Tenecteplase trials.
Int J Stroke 2020;15:507-515.
14. Powers WJ, Rabinstein AA, Ackerson T, Adeoye OM, Bambakidis NC, Becker K, et al. Guidelines for the early management of patients with acute ischemic stroke: 2019 update to the 2018 guidelines for the early management of acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association.
Stroke 2019;50:e344-e418.
15. Ducroux C, Khoury N, Lecler A, Blanc R, Chetrit A, Redjem H, et al. Application of the DAWN clinical imaging mismatch and DEFUSE 3 selection criteria: benefit seems similar but restrictive volume cut-offs might omit potential responders.
Eur J Neurol 2018;25:1093-1099.
16. Kent DM, Steyerberg E, van Klaveren D. Personalized evidence based medicine: predictive approaches to heterogeneous treatment effects.
BMJ 2018;363:k4245.
17. McMeekin P, Flynn D, Ford GA, Rodgers H, Gray J, Thomson RG. Development of a decision analytic model to support decision making and risk communication about thrombolytic treatment.
BMC Med Inform Decis Mak 2015;15:90.
18. Saposnik G, Goyal M, Majoie C, Dippel D, Roos Y, Demchuk A, et al. Visual aid tool to improve decision making in acute stroke care.
Int J Stroke 2016;11:868-873.
19. Decker C, Chhatriwalla E, Gialde E, Garavalia B, Summers D, Quinlan ME, et al. Patient-centered decision support in acute ischemic stroke: qualitative study of patients’ and providers’ perspectives.
Circ Cardiovasc Qual Outcomes 2015;8(6 Suppl 3):S109-S116.
21. Zaidat OO, Bozorgchami H, Ribó M, Saver JL, Mattle HP, Chapot R, et al. Primary results of the multicenter ARISE II study (Analysis of Revascularization in Ischemic Stroke With EmboTrap).
Stroke 2018;49:1107-1115.